Appearance and Performance-Enhancing Drugs and Supplements, Eating Disorders Symptoms, Drive for Muscularity, and Sexual Orientation in a Sample of Young Men.
Ata GhaderiElisabeth WelchPublished in: Nutrients (2022)
In an anonymous online study ( N = 824), we investigated the frequency of use of appearance and performance-enhancing drugs and supplements (APEDS) in a sample of young men (15-30 years) in Sweden, along with their self-reported eating disorder (ED) symptoms, drive for muscularity and sexual orientation. A total of 129 participants (16.1%) reported regular use of supplements (at least once a week), including one individual using anabolic steroids (0.1%), while a lifetime use of APEDS was reported by 32.3%. The overlap between those using protein supplements and creatine was large (83.6%). Some symptoms of ED (e.g., dietary restraint, objective binge eating, self-induced vomiting, and excessive exercise) significantly predicted the use of APEDS. In addition, the use of APEDS was significantly predicted by the drive for muscularity. The prediction was stronger for the behavioral component of drive for muscularity ( Exponential B = 8.50, B = 2.14, SE = 0.16, p < 0.001, Negelkerke R 2 = 0.517) than for its attitudinal component ( Exponential B = 1.52, B = 0.42, SE = 0.06, p < 0.001, Negelkerke R 2 = 0.088). A significantly larger proportion of those identifying as heterosexual reported using APEDS (34.4%) compared to those identifying themselves as homosexual (25.0%), bisexual (19.2%) or other (23.7%). Overall, our results suggest that the use of APEDS might be more related to the drive for muscularity and sexual orientation than symptoms of ED.
Keyphrases
- emergency department
- middle aged
- sleep quality
- physical activity
- randomized controlled trial
- men who have sex with men
- high intensity
- healthcare
- weight loss
- body mass index
- social media
- oxidative stress
- diabetic rats
- mass spectrometry
- health information
- small molecule
- high resolution
- study protocol
- hiv positive
- amino acid
- body composition
- stress induced
- antiretroviral therapy
- double blind